000 | 02002 a2200529 4500 | ||
---|---|---|---|
005 | 20250515130530.0 | ||
264 | 0 | _c20081031 | |
008 | 200810s 0 0 eng d | ||
022 | _a1523-6536 | ||
024 | 7 |
_a10.1016/j.bbmt.2008.05.008 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGaya, Anna | |
245 | 0 | 0 |
_aAnemia associated with impaired erythropoietin secretion after allogeneic stem cell transplantation: incidence, risk factors, and response to treatment. _h[electronic resource] |
260 |
_bBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation _cAug 2008 |
||
300 |
_a880-7 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAnemia _xdrug therapy |
650 | 0 | 4 | _aErythropoiesis |
650 | 0 | 4 |
_aErythropoietin _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHematinics |
650 | 0 | 4 |
_aHematologic Diseases _xcomplications |
650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 |
_aKidney Diseases _xetiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRecombinant Proteins |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTransplantation, Homologous |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aUrbano-Ispizua, Alvaro | |
700 | 1 | _aFernández-Avilés, Francesc | |
700 | 1 | _aSalamero, Olga | |
700 | 1 | _aRoncero, Josep María | |
700 | 1 | _aRovira, Montserrat | |
700 | 1 | _aMartínez, Carmen | |
700 | 1 | _aTalarn, Carme | |
700 | 1 | _aGranell, Miquel | |
700 | 1 | _aCarreras, Enric | |
700 | 1 | _aMontserrat, Emili | |
773 | 0 |
_tBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation _gvol. 14 _gno. 8 _gp. 880-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbmt.2008.05.008 _zAvailable from publisher's website |
999 |
_c18120639 _d18120639 |